BWX Technologies Other Income (Expense) increased by 110.8% to $625.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 113.0%, from -$4.81M to $625.00K. Over 3 years (FY 2021 to FY 2024), Other Income (Expense) shows a downward trend with a -13.8% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.18M | -$9.70M | $44.91M | $5.88M | $2.86M | $2.14M | -$45.08M | -$8.17M | -$8.73M | -$7.19M | -$37.57M | -$4.58M | -$7.18M | -$5.95M | -$14.17M | -$4.81M | -$4.67M | -$5.78M | $625.00K |
| QoQ Change | — | -287.2% | +563.0% | -86.9% | -51.3% | -25.1% | <-999% | +81.9% | -6.8% | +17.6% | -422.4% | +87.8% | -56.6% | +17.0% | -138.0% | +66.0% | +3.1% | -23.9% | +110.8% |
| YoY Change | — | — | — | — | -44.7% | +122.1% | -200.4% | -239.0% | -404.9% | -435.4% | +16.6% | +43.9% | +17.8% | +17.2% | +62.3% | -5.0% | +35.0% | +2.9% | +113.0% |